StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) income statement

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.37−0.05 (-0.92%)

Close on Nov 18, 2026Market cap $57.65MP/E –Yield –

PharmaCyte Biotech, Inc. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
-45.6%

Financial strength

Current ratio
40.30
Debt to equity
–
Debt to assets
–
Cash to current liabilities
2307.7%

Valuation

P/E ratio
–
Price to sales
–
Price to book
2.10
Dividend yield
–

See a number that looks wrong?